31, 2027, can be used for working capital and expenditures, including f inanc ing permitted acquisitions. Borrowings under the agreement, which matures on Aug. The agreement provides for a revolving credit faci lity of $1 billion, which can be increase d by $400 million subject to certain conditions. The company ended the first half of the year with cash and cash equivalents of $26.0 million.īio-Techne said in documents filed with the US Securities and Exchange Commission last week that it has entered into a credit agreement with BMO Harris Bank. Net loss was $12.6 million, or $.91 per share, compared to $261,721, or $.05 per share, in the first half of 202 1.
Mainz Biomed this week reported that its revenues for the first half of 2022 declined nearly 43 percent to $239,805 from $417, 311 in the year-ago period. The integration is also intended to help the institution expand its cancer research capabilities, as EMRs can now be searched for genomic results.
Oncologists will now be able to access genomic reports through the electronic medical records (EMR) system, which may help them more quickly identify potential treatments. Strata Oncology this week integrated its StrataNGS testing and reports with the University of Wisconsin Carbone Cancer Center and UW Health Epic genomics module. It is equipped with MGI's DNBSeq-T7, DNBSeq-G400, and DNBSeq-G50 sequencers, as well as the MGISP-NE32, MGISP-Smart8, MGISP-960, and MGISP-100 automation systems for nucleic acid extraction, liquid handling, and library preparation. The lab will provide technical assessments, product trials, clinical workflow validation, proof-of-concept programs, and technical support. MGI Tech said this week that it has opened a new demonstration laboratory in Tokyo to help local customers access its technologies and products. For the third quarter, Prenetics expects $65 million to $70 million in revenues. As of June 30, Prenetics had $134.4 million in cash and cash equivalents. For the quarter ended June 30, the diagnostics and genetic testing company, based in London and Hong Kong, booked a loss of $148.4 million, or $2.91 per share, compared to a loss of $9.9 million, or $.32 per share, during the same quarter a year ago. NEW YORK – Prenetics this week announced $51.7 million in revenues for the second quarter of 2022, down 35 percent from the same quarter a year ago.
0 kommentar(er)
